The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis (vol 44, pg 843, 2022)

被引：0

作者：

Cui, Yuying ^{[1
]}

Guo, Yingxue ^{[2
]}

机构：

[1] Jiamusi Univ, Sch Clin Med, Jiamusi 154007, Peoples R China

[2] Jiamusi Univ, Coll Pharm, Jiamusi 154007, Heilongjiang, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2024年 / 46卷 / 02期

关键词：

D O I：

10.1007/s11096-023-01682-x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：555 / 557

页数：3

共 50 条

[1] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis (vol 44, pg 843, 2022)
Cui, Yuying
Guo, Yingxue
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (04) : 1022 - 1023
[2] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis (vol 44, pg 843, 2022)
Cui, Yuying
Guo, Yingxue
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1572 - 1572
[3] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
Yuying Cui
Yingxue Guo
International Journal of Clinical Pharmacy, 2022, 44 : 843 - 851
[4] The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
Cui, Yuying
Guo, Yingxue
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) : 843 - 851
[5] Publisher Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis
Yuying Cui
Yingxue Guo
International Journal of Clinical Pharmacy, 2022, 44 : 1572 - 1572
[6] Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis
Yuying Cui
Yingxue Guo
International Journal of Clinical Pharmacy, 2024, 46 : 555 - 557
[7] Author Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis
Yuying Cui
Yingxue Guo
International Journal of Clinical Pharmacy, 2023, 45 : 1022 - 1023
[8] Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis
Kaveh, Sara
Ebrahimi, Parvin
Rezapour, Aziz
Mozafari, Masoud
Sayehmiri, Kourosh
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 30 - 41
[9] Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis
Sara Kaveh
Parvin Ebrahimi
Aziz Rezapour
Masoud Mozafari
Kourosh Sayehmiri
International Journal of Clinical Pharmacy, 2019, 41 : 30 - 41
[10] Effectiveness of bevacizumab in the treatment of metastatic colorectal cancer: a systematic review and meta-analysis
Song, Yu
Mao, Qianqian
Zhou, Manling
Liu, Cheng-Jiang
Kong, Li
Hu, Ting
BMC GASTROENTEROLOGY, 2024, 24 (01)

← 1 2 3 4 5 →